Publication | Closed Access

Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach

Drug SafetyUnknown FdaPredictive ToxicologyPreclinical Drug EvaluationMedicineBiostatisticsToxicologyPharmacologyDrug DiscoveryToxicogenomics